Dermatitis herpetiformis: Part I. Epidemiology, pathogenesis, and clinical presentation

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages 1017-1024

  Bolotin, Diana ^a   Petronic Rosic, Vesna ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

autoimmune bullous disease; blister; celiac disease; dermatitis herpetiformis; gliadin; gluten sensitive enteropathy; human leukocyte antigen DQ2; human leukocyte antigen DQ8; transglutaminase

Indexed keywords

GLIADIN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADDISON DISEASE; ALOPECIA AREATA; ATROPHIC GASTRITIS; BUTTOCK; CANCER RISK; DERMATITIS HERPETIFORMIS; DISEASE ASSOCIATION; GENDER; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; IRON DEFICIENCY; LUPUS ERYTHEMATOSUS; MUCOSA; NONHODGKIN LYMPHOMA; NONHUMAN; PAPULE; PATHOGENESIS; PATHOLOGY; PERNICIOUS ANEMIA; PREVALENCE; PRIORITY JOURNAL; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SCALP; SJOEGREN SYNDROME; VITILIGO;

ANIMALS; CELIAC DISEASE; COMORBIDITY; DERMATITIS HERPETIFORMIS; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOTHYROIDISM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOMA, NON-HODGKIN;

EID: 79956154255     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.09.777     Document Type: Review

References (87)

1. Duhring LA. Landmark article, Aug 30, 1884: Dermatitis herpetiformis. By Louis A. Duhring. JAMA 1983;250:212-6.
2. Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996;132:912-8. (Pubitemid 26266933)
3. Lever WF, Elder DE, editors. Lever's histopathology of the skin. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.
4. Mobacken H, Kastrup W, Nilsson LA. Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol 1984;64:400-4. (Pubitemid 14043137)
5. Reunala T, Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol 1978;58:505-10. (Pubitemid 9125831)
6. Moi H. Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Acta Derm Venereol 1984;64:144-50. (Pubitemid 14130455)
7. Gawkrodger DJ, Blackwell JN, Gilmour HM, Rifkind EA, Heading RC, Barnetson RS. Dermatitis herpetiformis: diagnosis, diet and demography. Gut 1984;25:151-7.
8. Smith JB, Tulloch JE, Meyer LJ, Zone JJ. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 1992;128:1608-10. (Pubitemid 23001177)
9. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study. BMJ 2008;337:a180.
10. Hall RP, Clark RE, Ward FE. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990;22:436-9. (Pubitemid 20212396)
11. Shibahara M, Nanko H, Shimizu M, Kanda N, Kubo M, Ikeda M, et al. Dermatitis herpetiformis in Japan: an update. Dermatology 2002;204:37-42. (Pubitemid 34136812)
12. Karell K, Korponay-Szabo I, Szalai Z, Holopainen P, Mustalahti K, Collin P, et al. Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs. Ann Hum Genet 2002;66:387-92. (Pubitemid 36007744)
13. Meyer LJ, Zone JJ. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987;17:643-7. (Pubitemid 17147809)
14. Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am J Clin Dermatol 2003;4:13-20. (Pubitemid 36078536)
15. Reunala TL. Dermatitis herpetiformis. Clin Dermatol 2001;19: 728-36. (Pubitemid 33035022)
16. Lanzini A, Villanacci V, Apillan N, Lanzarotto F, Pirali F, Amato M, et al. Epidemiological, clinical and histopathologic characteristics of celiac disease: results of a case-finding population-based program in an Italian community. Scand J Gastroenterol 2005;40:950-7. (Pubitemid 41117020)
17. Llorente-Alonso MJ, Fernandez-Acenero MJ, Sebastian M. Gluten intolerance: sex and age-related features. Can J Gastroenterol 2006;20:719-22. (Pubitemid 44941818)
18. Hervonen K, Karell K, Holopainen P, Collin P, Partanen J, Reunala T. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol 2000;115: 990-3. (Pubitemid 32037441)
19. Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002;37:51-5. (Pubitemid 34074733)
20. Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, et al. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 2006;67:341-5. (Pubitemid 43729359)
21. Koskinen LL, Korponay-Szabo IR, Viiri K, Juuti-Uusitalo K, Kaukinen K, Lindfors K, et al. Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association. J Med Genet 2008;45:222-7. (Pubitemid 351518727)
22. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341-4. (Pubitemid 41722189)
23. Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol 2007;5:1399-405.
24. Hunt KA, Monsuur AJ, McArdle WL, Kumar PJ, Travis SP, Walters JR, et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006;55:969-72. (Pubitemid 43962608)
25. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40:395-402. (Pubitemid 351450876)
26. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827-9. (Pubitemid 47014494)
27. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997;49:29-34.
28. Marietta E, Black K, Camilleri M, Krause P, Rogers RS 3rd, David C, et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 2004;114:1090-7. (Pubitemid 39578698)
29. Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 2002;169:5595-600. (Pubitemid 35291659)
30. Marsh MN. Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease. Nat Med 1997;3:725-6. (Pubitemid 27298712)
31. Nicolas ME, Krause PK, Gibson LE, Murray JA. Dermatitis herpetiformis. Int J Dermatol 2003;42:588-600. (Pubitemid 37025207)
32. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801. (Pubitemid 27298728)
33. Caputo I, Barone MV, Martucciello S, Lepretti M, Esposito C. Tissue transglutaminase in celiac disease: role of autoantibodies. Amino Acids 2009;36:693-9.
34. Schuppan D, Dieterich W, Riecken EO. Exposing gliadin as a tasty food for lymphocytes. Nat Med 1998;4:666-7. (Pubitemid 28274661)
35. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci 2004;34:83-90. (Pubitemid 38368946)
36. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-7. (Pubitemid 28274673)
37. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-42.
38. Smith JB, Taylor TB, Zone JJ. The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol 1992;27:209-13.
39. Zone JJ, Egan CA, Taylor TB, Meyer LJ. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004;9:47-51. (Pubitemid 38096198)
40. Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T, et al. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol 2008;159:120-4. (Pubitemid 351874506)
41. Kawana S, Segawa A. Confocal laser scanning microscopic and immunoelectron microscopic studies of the anatomical distribution of fibrillar IgA deposits in dermatitis herpetiformis. Arch Dermatol 1993;129:456-9. (Pubitemid 23118241)
42. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002;195:747-57. (Pubitemid 34259719)
43. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4: 140-56. (Pubitemid 36172696)
44. Hitomi K. Transglutaminases in skin epidermis. Eur J Dermatol 2005;15:313-9. (Pubitemid 41337406)
45. Jaskowski TD, Hamblin T, Wilson AR, Hill HR, Book LS, Meyer LJ, et al. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease. J Invest Dermatol 2009;129:2728-30.
46. Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol 2009;61:39-43.
47. Leonard J, Haffenden G, Tucker W, Unsworth J, Swain F, McMinn R, et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983;308:816-9. (Pubitemid 13114678)
48. Charlesworth EN, Backe JT, Garcia RL. Iodide-induced immunofluorescence in dermatitis herpetiformis. Arch Dermatol 1976;112:555.
49. Katz KA, Roseman JE, Roseman RL, Katz SI. Dermatitis herpetiformis flare associated with use of triiodomethane packing strips for alveolar osteitis. J Am Acad Dermatol 2009;60:352-3.
50. Lear JT, English JS, Jones PW. Adult coeliac disease, dermatitis herpetiformis and smoking. Gut 1997;40:289. (Pubitemid 27093111)
51. Smith JB, Smith SB, Zone JJ. Dermatitis herpetiformis and cigarette smoking. Gut 1998;43:732.
52. Snook JA, Dwyer L, Lee-Elliott C, Knan S, Wheeler DW, Nicholas DS, et al. Smoking benefits celiac sprue and pouchitis: implications for nicotine therapy? Gastroenterology 1997;112:1048-50.
53. Snook JA, Dwyer L, Lee-Elliott C, Khan S, Wheeler DW, Nicholas DS. Adult coeliac disease and cigarette smoking. Gut 1996;39: 60-2. (Pubitemid 26239106)
54. Austin AS, Logan RF, Thomason K, Holmes GK. Cigarette smoking and adult coeliac disease. Scand J Gastroenterol 2002;37:978-82. (Pubitemid 34969935)
55. Zone JJ. Skin manifestations of celiac disease. Gastroenterology 2005;128(4 suppl. 1):S87-91.
56. Marks R, Jones EW. Purpura in dermatitis herpetiformis. Br J Dermatol 1971;84:386-8.
57. McCleskey PE, Erickson QL, David-Bajar KM, Elston DM. Palmar petechiae in dermatitis herpetiformis: a case report and clinical review. Cutis 2002;70:217-23. (Pubitemid 41757446)
58. McGovern TW, Bennion SD. Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis. Pediatr Dermatol 1994;11:319-22.
59. Pierce DK, Purcell SM, Spielvogel RL. Purpuric papules and vesicles of the palms in dermatitis herpetiformis. J Am Acad Dermatol 1987;16:1274-6.
60. Hofmann SC, Nashan D, Bruckner-Tuderman L. Petechiae on the fingertips as presenting symptom of dermatitis herpetiformis Duhring. J Eur Acad Dermatol Venereol 2009;23:732-3.
61. Lahteenoja H, Irjala K, Viander M, Vainio E, Toivanen A, Syrjanen S. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998;134:756-8. (Pubitemid 28283735)
62. Lahteenoja H, Toivanen A, Viander M, Maki M, Irjala K, Raiha I, et al. Oral mucosal changes in coeliac patients on a gluten-free diet. Eur J Oral Sci 1998;106:899-906. (Pubitemid 128737080)
63. da Silva PC, de Almeida Pdel V, Machado MA, de Lima AA, Gregio AM, Trevilatto PC, et al. Oral manifestations of celiac disease. A case report and review of the literature. Med Oral Patol Oral Cir Bucal 2008;13:E559-62.
64. Campisi G, Di Liberto C, Iacono G, Compilato D, Di Prima L, Calvino F, et al. Oral pathology in untreated coeliac [corrected] disease. Aliment Pharmacol Ther 2007;26:1529-36. (Pubitemid 350182351)
65. Aine L, Maki M, Reunala T. Coeliac-type dental enamel defects in patients with dermatitis herpetiformis. Acta Derm Venereol 1992;72:25-7.
66. Aine L, Reunala T, Maki M. Dental enamel defects in children with dermatitis herpetiformis. J Pediatr 1991;118:572-4.
67. Maki M, Aine L, Lipsanen V, Koskimies S. Dental enamel defects in first-degree relatives of coeliac disease patients. Lancet 1991;337:763-4.
68. Maki M, Collin P. Coeliac disease. Lancet 1997;349:1755-9. (Pubitemid 27252682)
69. Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol 1991;9:347-60.
70. Gaspari AA, Huang CM, Davey RJ, Bondy C, Lawley TJ, Katz SI. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990;88:145-50. (Pubitemid 20051786)
71. Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest 2000;30:53-7. (Pubitemid 30071857)
72. Hervonen K, Viljamaa M, Collin P, Knip M, Reunala T. The occurrence of type 1 diabetes in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 2004;150:136-8. (Pubitemid 38234018)
73. Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008;31:160-5.
74. Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, et al. Diabetes prevalence in England, 2001 - estimates from an epidemiological model. Diabet Med 2006; 23:189-97.
75. Reunala T, Salmi J, Karvonen J. Dermatitis herpetiformis and celiac disease associated with Addison's disease. Arch Dermatol 1987;123:930-2. (Pubitemid 17090485)
76. Amato L, Gallerani I, Fuligni A, Mei S, Fabbri P. Dermatitis herpetiformis and vitiligo: report of a case and review of the literature. J Dermatol 2000;27:462-6. (Pubitemid 30620264)
77. Karabudak O, Dogan B, Yildirim S, Harmanyeri Y, Anadolu-Brasie R. Dermatitis herpetiformis and vitiligo. J Chin Med Assoc 2007;70:504-6. (Pubitemid 350285075)
78. Stavropoulos PG, Moustou AE, Tsiougou M, Avgerinou G, Chatziolou E, Katsambas A. Might dermatitis herpetiformis be associated with discoid lupus erythematosus? J Eur Acad Dermatol Venereol 2008;22:749-50.
79. Bianchi ML, Bardella MT. Bone in celiac disease. Osteoporos Int 2008;19:1705-16.
80. Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, Aliberti F, et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004;19: 1112-21. (Pubitemid 41110563)
81. Lewis NR, Logan RF, Hubbard RB, West J. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2008;27:1140-7. (Pubitemid 351614881)
82. Abuzakouk M, Barnes L, O'Gorman N, O'Grady A, Mohamed B, McKenna MJ, et al. Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig Dis Sci 2007;52:659-64.
83. Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996;38:528-30. (Pubitemid 26111372)
84. Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 2005;152:82-6.
85. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year populationbased study. Dig Liver Dis 2006;38:374-80. (Pubitemid 44356222)
86. Sigurgeirsson B, Agnarsson BA, Lindelof B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308:13-5.
87. Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135:363-7. (Pubitemid 26297828)